Please Wait.....
Report
Latin America Biosimulation Market Report and Forecast 2024-2032
Market Report I 2024-06-26 I 140 Pages I EMR Inc.
Latin America Biosimulation Market Report and Forecast 2024-2032
Latin America Biosimulation Market Size
The global biosimulation market was valued at USD 3.5 billion in 2023, with Latin America holding a significant market share. The market is driven by the increased focus on pharmaceutical research and development. It is expected to grow at a CAGR of 16.90% during the forecast period of 2024-2032, with the values likely to attain USD 14.1 billion by 2032.
Latin America Biosimulation Market Outlook
- This rising prevalence of chronic diseases is fuelling the adoption of biosimulation tools in the Latin American region, leading to accelerated drug development process and improved patient outcomes, thereby bolstering market growth.
- One of the major Latin America biosimulation market trends is the increased investment in research and development (R&D), particularly in the life sciences domain, which is poised to support the market expansion for biosimulation tools and services.
- According to the International Trade Administration, Brazil has the largest healthcare market in Latin America, spending 9.47% of its GDP on healthcare, which amounts to USD 161 billion. The increased allocation of resources to healthcare is likely to augment the market demand for advanced solutions like biosimulation software.
Latin America Biosimulation Market Analysis
Biosimulation is a robust tool to model and simulate biological processes. Biosimulation models help to mimic the behavior of biological systems and offer insights into their functions, interactions, and responses to various conditions. They can help identify potential drug candidates and predict adverse effects before conducting clinical trials, thus, saving time and money. The growing adoption of biosimulation technologies to accelerate the drug development process and improve patient outcomes is significantly contributing to the Latin America biosimulation market growth.
In Latin America, chronic diseases are a major cause of premature death, decreased quality of life, and substantial economic burden. This rising prevalence of chronic diseases is influencing the adoption of biosimulation tools to develop novel therapeutics for these conditions. Biosimulation techniques not only help in predicting long-term outcomes of therapies but also enhance the design of clinical trials, thus leading to improved patient outcomes. Further, personalized medicine is gaining traction in the region, driven by the understanding that genetic factors considerably impact drug response. The growing interest in personalized medicine and precision care is likely to augment the Latin America biosimulation market demand.
Latin American countries are gradually increasing their investment in research and development (R&D), particularly in the life sciences domain, which is anticipated to fuel the market share. In December 2023, a study published in the Journal of Law Medicine & Ethics revealed that R&D expenditure is rising in the region, with Brazil spending the largest share of their GDP on healthcare research. Some countries in the Latin American region were reported to make notable progress in pharmaceutical and biotechnology outputs. Thus, the increasing R&D spending is poised to bolster the demand for biosimulation tools and services to support pharmaceutical innovation.
Various factors such as rising healthcare spending, favorable regulatory policies, and the expansion of the pharmaceutical industry are likely to elevate the Latin America biosimulation market value. According to the International Trade Administration, Brazil has the largest healthcare market in Latin America, spending 9.47% of its GDP on healthcare, which amounts to USD 161 billion. With more resources allocated to healthcare, the demand for advanced solutions such as biosimulation software is anticipated to increase in drug discovery and development activities, which will ultimately support the market growth.
Latin America Biosimulation Market Segmentation??
The report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Services
Software
Market Breakup by Application
Drug Development
Drug Discovery
Other Applications
Market Breakup by Delivery Type
Subscription Model
Ownership Model
Market Breakup by End User
Biotechnology and Pharmaceutical Companies
Research Institutes
Regulatory Authorities
Contract Research Organizations
Market Breakup by Country
Brazil
Argentina
Mexico
Others
Leading Players in the Latin America Biosimulation Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- In Silico Biosciences
- Biosimulation Solutions LLC
- Solvias
- QuantumBio
- Biosimulation Technology
- Biocellion
- Certara
- Simulations Plus
- Rhenovia Pharma
- Heuristik
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
FAQs
- What is the Latin America biosimulation market forecast outlook for 2024-2032?
The Latin America biosimulation market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 16.90% during the forecast period of 2024-2032 and is likely to reach a market value of USD 14.1 billion by 2032.
- What are the major factors aiding the Latin America biosimulation market demand?
The rising advancement in biosimulation software and rising healthcare investments is fuelling the demand for the market.
- What are the major Latin America biosimulation market trends?
One of the significant trends in the market is the rising investment in research and development (R&D) which is poised to bolster the demand for biosimulation tools and services. In December 2023, a Journal of Law Medicine & Ethics study revealed that R&D expenditure is rising in the region, with Brazil spending the largest share of its GDP on healthcare research.
- What is the market segmentation based on the product type?
Based on the product type, the market is segmented into services and software.
- What is the market breakup by delivery type?
By delivery type, the market is divided into the subscription model and ownership model.
- What are the major end users of the market?
End users of the market are biotechnology & pharmaceutical companies, research institutes, regulatory authorities, and contract research organizations.
- What are the applications of biosimulation?
Major applications of biosimulation include drug development, and drug discovery, among other applications.
- What is the market segmentation by countries?
The market segmentation by countries includes Brazil, Argentina, and Mexico, among others.
- Who are the key players involved in the Latin America biosimulation market?
The key players in the market are In Silico Biosciences, Biosimulation Solutions LLC, Solvias, QuantumBio, Biosimulation Technology, Biocellion, Certara, Simulations Plus, Rhenovia Pharma, and Heuristik.
Meta description
The Latin America biosimulation market is poised for growth, driven by the expansion of the global market, which was valued at USD 3.5 billion in 2023 and is projected to grow at a CAGR of 16.90% during the forecast period of 2024-2032.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Latin America Biosimulation Market Overview
3.1 Latin America Biosimulation Market Historical Value (2017-2023)
3.2 Latin America Biosimulation Market Forecast Value (2024-2032)
4 Latin America Biosimulation Market Landscape*
4.1 Latin America Biosimulation: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Latin America Biosimulation: Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Application
5 Latin America Biosimulation Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter's Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Latin America Biosimulation Market Segmentation (2017-2032)
6.1 Latin America Biosimulation Market (2017-2032) by Product Type
6.1.1 Market Overview
6.1.2 Services
6.1.3 Software
6.2 Latin America Biosimulation Market (2017-2032) by Application
6.2.1 Market Overview
6.2.2 Drug Development
6.2.3 Drug Discovery
6.2.4 Other Application
6.3 Latin America Biosimulation Market (2017-2032) by Delivery Type
6.3.1 Market Overview
6.3.2 Subscription Model
6.3.3 Ownership Model
6.4 Latin America Biosimulation Market (2017-2032) by End User
6.4.1 Market Overview
6.4.2 Biotechnology & Pharmaceutical Companies
6.4.3 Research Institutes
6.4.4 Regulatory Authorities
6.4.5 Contract Research Organizations
6.5 Latin America Biosimulation Market (2017-2032) by Country
6.5.1 Market Overview
6.5.2 Brazil
6.5.3 Argentina
6.5.4 Mexico
6.5.5 Others
7 Brazil Biosimulation Market (2017-2032)
7.1 Brazil Biosimulation Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Services
7.1.3 Software
7.2 Brazil Biosimulation Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Drug Development
7.2.3 Drug Discovery
7.2.4 Other Application
7.3 Brazil Biosimulation Market (2017-2032) by Delivery Type
7.3.1 Market Overview
7.3.2 Subscription Model
7.3.3 Ownership Model
7.4 Brazil Biosimulation Market (2017-2032) by End User
7.4.1 Market Overview
7.4.2 Biotechnology & Pharmaceutical Companies
7.4.3 Research Institutes
7.4.4 Regulatory Authorities
7.4.5 Contract Research Organizations
8 Argentina Biosimulation Market (2017-2032)
8.1 Argentina Biosimulation Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Services
8.1.3 Software
8.2 Argentina Biosimulation Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Drug Development
8.2.3 Drug Discovery
8.2.4 Other Application
8.3 Argentina Biosimulation Market (2017-2032) by Delivery Type
8.3.1 Market Overview
8.3.2 Subscription Model
8.3.3 Ownership Model
8.4 Argentina Biosimulation Market (2017-2032) by End User
8.4.1 Market Overview
8.4.2 Biotechnology & Pharmaceutical Companies
8.4.3 Research Institutes
8.4.4 Regulatory Authorities
8.4.5 Contract Research Organizations
9 Mexico Biosimulation Market (2017-2032)
9.1 Mexico Biosimulation Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Services
9.1.3 Software
9.2 Mexico Biosimulation Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Drug Development
9.2.3 Drug Discovery
9.2.4 Other Application
9.3 Mexico Biosimulation Market (2017-2032) by Delivery Type
9.3.1 Market Overview
9.3.2 Subscription Model
9.3.3 Ownership Model
9.4 Mexico Biosimulation Market (2017-2032) by End User
9.4.1 Market Overview
9.4.2 Biotechnology & Pharmaceutical Companies
9.4.3 Research Institutes
9.4.4 Regulatory Authorities
9.4.5 Contract Research Organizations
10 Regulatory Framework
11 Funding and Investment Analysis
11.1 Analysis by Funding Instances
11.2 Analysis by Type of Funding
11.3 Analysis by Funding Amount
11.4 Analysis by Leading Players
11.5 Analysis by Leading Investors
11.6 Analysis by Geography
12 Partnership and Collaborations Analysis
12.1 Analysis by Partnership Instances
12.2 Analysis by Type of Partnership
12.3 Analysis by Leading Players
12.4 Analysis by Geography
13 Supplier Landscape
13.1 Market Share by Top 5 Companies
13.2 In Silico Biosciences
13.2.1 Financial Analysis
13.2.2 Product Portfolio
13.2.3 Demographic Reach and Achievements
13.2.4 Mergers and Acquisitions
13.2.5 Certifications
13.3 Biosimulation Solutions LLC
13.3.1 Financial Analysis
13.3.2 Product Portfolio
13.3.3 Demographic Reach and Achievements
13.3.4 Mergers and Acquisitions
13.3.5 Certifications
13.4 Solvias
13.4.1 Financial Analysis
13.4.2 Product Portfolio
13.4.3 Demographic Reach and Achievements
13.4.4 Mergers and Acquisitions
13.4.5 Certifications
13.5 QuantumBio
13.5.1 Financial Analysis
13.5.2 Product Portfolio
13.5.3 Demographic Reach and Achievements
13.5.4 Mergers and Acquisitions
13.5.5 Certifications
13.6 Biosimulation Technology
13.6.1 Financial Analysis
13.6.2 Product Portfolio
13.6.3 Demographic Reach and Achievements
13.6.4 Mergers and Acquisitions
13.6.5 Certifications
13.7 Biocellion
13.7.1 Financial Analysis
13.7.2 Product Portfolio
13.7.3 Demographic Reach and Achievements
13.7.4 Mergers and Acquisitions
13.7.5 Certifications
13.8 Certara
13.8.1 Financial Analysis
13.8.2 Product Portfolio
13.8.3 Demographic Reach and Achievements
13.8.4 Mergers and Acquisitions
13.8.5 Certifications
13.9 Simulations Plus
13.9.1 Financial Analysis
13.9.2 Product Portfolio
13.9.3 Demographic Reach and Achievements
13.9.4 Mergers and Acquisitions
13.9.5 Certifications
13.10 Rhenovia Pharma
13.10.1 Financial Analysis
13.10.2 Product Portfolio
13.10.3 Demographic
13.10.4 Mergers and Acquisitions
13.10.5 Certifications
13.11 Heuristik
13.11.1 Financial Analysis
13.11.2 Product Portfolio
13.11.3 Demographic Reach and Achievements
13.11.4 Mergers and Acquisitions
13.11.5 Certifications
14 Latin America Biosimulation Market - Distribution Model (Additional Insight)
14.1 Overview
14.2 Potential Distributors
14.3 Key Parameters for Distribution Partner Assessment
15 Key Opinion Leaders (KOL) Insights (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
16.1 Very Small Companies
16.2 Small Companies
16.3 Mid-Sized Companies
16.4 Large Companies
16.5 Very Large Companies
17 Payment Methods (Additional Insight)
17.1 Government Funded
17.2 Private Insurance
17.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security